CompletedNCT05040256
Neurologic and Immunologic Characteristics of CTLA-4 and LRBA Hereditary Deficiency
Studying Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Montpellier
- Principal Investigator
- Xavier Ayrignac, MDUniversity Hospital, Montpellier
- Enrollment
- 20 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2021 – 2021
Study locations (1)
- Uhmontpellier, Montpellier, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05040256 on ClinicalTrials.govOther trials for Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency
Additional recruiting or active studies for the same condition.
See all trials for Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency →